Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
42.06(c) 41.85(c) 41.42(c) 41.67(c) 41.49(c) Last
11 984 161 16 222 295 28 205 715 17 590 308 23 503 596 Volume
-0.92% -0.50% -1.03% +0.60% -0.43% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 81 101 M - -
Net income 2021 18 457 M - -
Net Debt 2021 29 308 M - -
P/E ratio 2021 12,3x
Yield 2021 3,80%
Sales 2022 69 471 M - -
Net income 2022 16 495 M - -
Net Debt 2022 23 087 M - -
P/E ratio 2022 13,2x
Yield 2022 3,95%
Capitalization 233 B 233 B -
EV / Sales 2021 3,23x
EV / Sales 2022 3,68x
Nbr of Employees 78 500
Free-Float 59,3%
More Financials
Company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines... 
Sector
Pharmaceuticals
Calendar
11/02Earnings Release
More about the company
Ratings of Pfizer, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about PFIZER, INC.
04:24aPFIZER : United States Donates 1.6 Million More COVID-19 Pfizer Vaccines to Egypt This is ..
AQ
10/16MODERNA : U.S. administers 407.4 mln doses of COVID-19 vaccines -CDC
RE
10/15PFIZER : States can reserve COVID-19 shots for younger kids next week
AQ
10/15FDA panel recommends J&J COVID-19 booster for all recipients who got first shot
AQ
10/15MODERNA : COVID SCIENCE-Statins may slightly lower COVID-19 death risk; using a different ..
RE
10/15PFIZER : FDA panel endorses booster shot for J&J COVID-19 vaccine
AQ
10/15MODERNA : U.S. FDA delays decision on Moderna's COVID-19 vaccine for adolescents - WSJ
RE
10/15PFIZER : FDA panel takes up tough questions on J&J COVID-19 boosters
AQ
10/15MODERNA : U.S. FDA advisers to vote on J&J COVID-19 vaccine booster
RE
10/15THE LATEST : Pfizer seeks European OK for child vaccines
AQ
10/15PFIZER : BioNTech ask EU agency to OK vaccine for kids 5-11
AQ
10/15PFIZER : BioNTech Makes European Medicines Agency Submission of Data Focusing COVID-19 Vac..
MT
10/15BIONTECH : Pfizer Seek European Medicines Agency's Approval for COVID-19 Vaccine for Young..
MT
10/15RBC on The Day Ahead in Canada; BoC Governor Largely Reiterating Views
MT
10/15PFIZER : Abrocitinib Receives Positive Opinion From European Regulator
MT
More news
News in other languages on PFIZER, INC.
10/15USA : un comité d'experts recommande une dose supplémentaire au vaccin anti-
10/15Biontech beantragt EU-Zulassung von Corona-Impfstoff für Kinder
10/15Biontech und Pfizer beantragen Impfstoff-Zulassung für Kinder
10/15PFIZER : vers la mise sur le marché européen de l'abrocitinib
10/15VACCIN POUR LES 5-11 ANS : Pfizer/BioNTech transmettent des données à l'EMA
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 41,49 $
Average target price 45,72 $
Spread / Average Target 10,2%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.13.20%232 621
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283